What 2026's IPO Boom Really Tells Us

For the better part of three years, the initial public offering (IPO) market “window” was a punchline—it kept threatening to open and never quite did. In 2026, it didn't so much open as blow off its hinges.

Through the first half of 2026, U.S. companies have raised roughly $251 billion across 86 IPOs, more than five times the total value of all of 2025, and the largest since the 2021 boom. That said, before declaring this a durable new IPO bull cycle, it's worth looking at the source of this growth.

The Reopening, By the Numbers

U.S. IPO proceeds have climbed steadily out of the 2022 trough, resulting in a genuine, broad-based recovery. 2026, however, is a different animal.

SpaceX's June listing alone raised $75 billion, more than the entirety of 2024 and 2025 combined, at a $1.7 trillion valuation, instantly making it one of the largest public companies on U.S. exchanges. Renaissance Capital, which has tracked the IPO market since the 1990s, noted that even without SpaceX, the second quarter would still have been the biggest for IPO proceeds since 2021, powered by nine other billion-dollar-plus deals led by AI chipmaker Cerebras. That's the nuance the headline numbers miss: the IPO window reopening is real, but it is also unusually top-heavy.

What's Actually Priced—and What's Still in the Pipeline

Beyond SpaceX, the class of 2026 has skewed toward scale and profitability rather than the venture-backed growth names that defined 2021. Blackstone-backed medical supplier Medline's $6.3 billion offering, the largest deal since 2021 prior to SpaceX, set the tone in late 2025. Quantum computing firm Quantinuum was valued at $17.6 billion when shares first began trading, a sharp step up from its $10 billion private valuation in 2025.

The pipeline for the rest of 2026 will test the "durable recovery" thesis. Anthropic, the AI research lab behind the Claude chatbot, has reportedly filed at a $965 billion valuation, with an eye toward an October listing. OpenAI, the AI research lab behind ChatGPT, has reportedly been exploring its own path to the public markets. Not everyone is rushing, however. Databricks, an enterprise data and AI infrastructure software company, has reportedly pushed its listing plans out to 2027, a reminder that issuers with leverage still have the luxury of waiting for better terms rather than taking what the market offers today.

Importantly, this remains a sellers’ choice environment, not a company-must-go-public one. PitchBook and NVCA data on the broader private company landscape found that in 2025, acquisitions outnumbered public listings roughly 16-to-1 among venture capital (VC)-backed companies and accounted for 94% of all exit events. While the IPO market window appears to be reopening, it is not yet the primary exit ramp for the venture and private equity ecosystem, which sits on a multi-year backlog of mature portfolio companies.

What It Means for the Broader Market

Three things are worth watching as this plays out:

1. Concentration keeps compounding. The S&P 500's top seven names already are a modern record, accounting for roughly a third of the index's market value. When companies the size of SpaceX or Anthropic go public and are added to major indices, they don't necessarily diversify that concentration; they likely add to it. For portfolios built around individual securities rather than index funds, this is a reminder of why security selection, not simply "the market," remains the relevant unit of analysis.
2. Aftermarket discipline still matters. Bloomberg data shows the 2026 class of IPOs has traded reasonably well in 2026, averaging roughly a 16% return from offer through the second quarter—solid, but nowhere near 2021's speculative excess. That's a healthier signal than the headline dollar figures alone suggest.
3. One deal does not make a cycle. With SpaceX representing roughly 30% of 2026's total proceeds, the "record year" narrative is more fragile than the topline number implies. Whether 2026 marks a genuine, multi-year reopening or simply the year a handful of extraordinary companies happened to list will depend on how the pipeline behind Anthropic performs once the market's attention moves on.

For us, the practical takeaway isn't to chase headline IPOs at the offer price, but to treat this as a capital-markets health indicator. A reopening IPO market generally signals confidence, available liquidity and investor risk appetite—generally a constructive sign for equities broadly, even for those of us who won't own SpaceX or Anthropic directly. We'll be watching the back half of the 2026 pipeline, not just the deals already done, for a clearer read on whether this year is a turning point or an outlier.

And to be clear: a newly public company does not earn its place in client portfolios because of IPO headlines. It only earns a place in if it clears our rigorous fundamental analysis, not because its IPO makes headlines.

Takeaways for the Week

• July nonfarm payrolls fell by 23,000—even as unemployment ticked down to 4.1%—and markets read the miss as reducing the odds of a Fed rate hike at the September meeting, helping stocks post a second straight week of gains
• July CPI came in exactly as market analysts expected, keeping the Fed on hold. Headline CPI rose 0.1% month-over-month (3.4% year-over-year) and core CPI rose 0.2% (2.5% year-over-year), reinforcing the case for the Fed to leave rates unchanged in September even with inflation still running above its 2% target
• The S&P 500 and Nasdaq hit fresh records. The S&P 500 closed above 7,700 for the first time this week and touched a new intraday high above 7,800 on Thursday, with a rebound in semiconductor stocks (the SOXX ETF rose more than 7% on the week) driving a 5.2% weekly gain in the Nasdaq

Disclosure

The views expressed represent the opinion of Ferguson Wellman. The views are subject to change and are not intended as a forecast or guarantee of future results. This material is for informational purposes only. It does not constitute investment advice and is not intended as an endorsement of any specific investment. Statements of future expectations, estimates, projections and other forward-looking statements are based on available information and Ferguson Wellman’s views as of the time of these statements. Past performance may not be indicative of future results. Ferguson Wellman, Octavia Group and West Bearing do not provide tax, legal, insurance or medical advice. This material has been prepared for general educational purposes only and not as a substitute for qualified counsel who can determine how this information applies to you. We believe the information provided is from reliable sources but should not be assumed accurate or complete.

Please see additional disclosures.